Cargando…

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease

Parkinson’s disease (PD) is characterized by loss of dopaminergic neurons in substantia nigra pars compacta, α-synuclein (α-syn)-rich intraneuronal inclusions (Lewy bodies), and microglial activation. Emerging evidence suggests that CD4+ T lymphocytes contribute to neuroinflammation in PD. Since the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kustrimovic, Natasa, Rasini, Emanuela, Legnaro, Massimiliano, Bombelli, Raffaella, Aleksic, Iva, Blandini, Fabio, Comi, Cristoforo, Mauri, Marco, Minafra, Brigida, Riboldazzi, Giulio, Sanchez-Guajardo, Vanesa, Marino, Franca, Cosentino, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031979/ https://www.ncbi.nlm.nih.gov/pubmed/27652978 http://dx.doi.org/10.1038/srep33738

Ejemplares similares

Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients
por: Kustrimovic, Natasa, et al.
Publicado: (2018)

Dataset of mRNA levels for dopaminergic receptors, adrenoceptors and tyrosine hydroxylase in lymphocytes from subjects with clinically isolated syndromes
por: Cosentino, Marco, et al.
Publicado: (2016)

Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment
por: Kustrimovic, Natasa, et al.
Publicado: (2023)

Effect of Cannabidiol on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa–Induced Dyskinesia in Parkinson’s Disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Do Th17 Lymphocytes and IL-17 Contribute to Parkinson's Disease? A Systematic Review of Available Evidence
por: Storelli, Elisa, et al.
Publicado: (2019)

Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment
por: Marino, Franca, et al.
Publicado: (2012)

Dopaminergic Stimulation of Myeloid Antigen-Presenting Cells Attenuates Signal Transducer and Activator of Transcription 3-Activation Favouring the Development of Experimental Autoimmune Encephalomyelitis
por: Prado, Carolina, et al.
Publicado: (2018)

Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson’s Disease: A Single-Center Longitudinal Study
por: Contaldi, Elena, et al.
Publicado: (2022)

The PROB-PD trial: a pilot, randomised, placebo-controlled study protocol to evaluate the feasibility and potential efficacy of probiotics in modulating peripheral immunity in subjects with Parkinson’s disease
por: Martini, Stefano, et al.
Publicado: (2023)

Editorial: Peripheral Immunity in Parkinson's Disease: Emerging Role and Novel Target for Therapeutics
por: Comi, Cristoforo, et al.
Publicado: (2019)

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study
por: Contaldi, Elena, et al.
Publicado: (2021)

Expression of Transcription Factors in CD4 + T Cells as Potential Biomarkers of Motor Complications in Parkinson’s Disease
por: Contaldi, Elena, et al.
Publicado: (2021)

Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?
por: Furgiuele, Alessia, et al.
Publicado: (2023)

Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells
por: Fanelli, Roberto, et al.
Publicado: (2014)

Polymorphisms of Dopamine Receptor Genes and Parkinson’s Disease: Clinical Relevance and Future Perspectives
por: Magistrelli, Luca, et al.
Publicado: (2021)

A Novel Standardized Cannabis sativa L. Extract and Its Constituent Cannabidiol Inhibit Human Polymorphonuclear Leukocyte Functions
por: Mabou Tagne, Alex, et al.
Publicado: (2019)

Functional single nucleotide polymorphisms in dopaminergic receptors D2 predict clinical response to Cariprazine
por: De Pieri, Marco, et al.
Publicado: (2023)

Striatal dopamine transporter imaging in Parkinson’s disease drug-naïve patients: focus on sexual dysfunction
por: Contaldi, Elena, et al.
Publicado: (2022)

Dopaminergic Receptors and Tyrosine Hydroxylase Expression in Peripheral Blood Mononuclear Cells: A Distinct Pattern in Central Obesity
por: Leite, Fernanda, et al.
Publicado: (2016)

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey
por: Martini, Stefano, et al.
Publicado: (2022)

Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2015)

Correction: Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2017)

Progression to vascular dementia of patients with mild cognitive impairment: relevance of mild parkinsonian signs
por: Mauri, Marco, et al.
Publicado: (2008)

The Exosomal/Total α-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
por: Cerri, Silvia, et al.
Publicado: (2018)

Alzheimer’s Disease: From Immune Homeostasis to Neuroinflammatory Condition
por: Princiotta Cariddi, Lucia, et al.
Publicado: (2022)

Selegiline reduces daytime sleepiness in patients with Parkinson's disease
por: Gallazzi, Marco, et al.
Publicado: (2021)

Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: a longitudinal study during atorvastatin treatment
por: Guasti, Luigina, et al.
Publicado: (2016)

Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy
por: Cosentino, Marco, et al.
Publicado: (2005)

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease
por: Lee, Yang Hyun, et al.
Publicado: (2019)

Exploring the levodopa-paradox of freezing of gait in dopaminergic medication-naïve Parkinson’s disease populations
por: Jansen, Jamie A. F., et al.
Publicado: (2023)

Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
por: Pellegrini, Carolina, et al.
Publicado: (2016)

Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
por: Cosentino, Marco, et al.
Publicado: (2022)

The spike hypothesis in vaccine-induced adverse effects: questions and answers
por: Cosentino, Marco, et al.
Publicado: (2022)

In response to Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination
por: Cosentino, Marco, et al.
Publicado: (2023)

In vivo and in vitro Development of Human Mesencephalic Dopaminergic Neurons
por: Silani, Vincenzo, et al.
Publicado: (1992)

Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals
por: Cosentino, Marco, et al.
Publicado: (2021)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Non-Medical Radiography Staff Experiences in Inter-Professional Communication: A Swedish Qualitative Focus Group Interview Study
por: Fatahi, Nabi, et al.
Publicado: (2020)

How Does Vitamin D Affect Immune Cells Crosstalk in Autoimmune Diseases?
por: Gallo, Daniela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pmt45qfevbp777vjj6f33d5ei5